Phase I Trial of ECI301 in Combination With Radiation in Patients With Advanced or Metastatic Cancer

Trial Profile

Phase I Trial of ECI301 in Combination With Radiation in Patients With Advanced or Metastatic Cancer

Discontinued
Phase of Trial: Phase I

Latest Information Update: 19 May 2017

At a glance

  • Drugs ECI 301 (Primary)
  • Indications Cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 01 Apr 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 08 Apr 2012 Additional lead trial centre and investigator identified as reported by University Hospital Medical Information Network - Japan.
    • 08 Apr 2012 Additional trial location (Japan) identified as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top